We’re pleased to announce that Michael Boyne, Co-Founder and Principal at CatalystBio, will be sharing his expertise at the American Institute for Medical and Biological Engineering (AIMBE) Annual Meeting this Sunday, March 30th.
Michael will be speaking on one of his favorite topics: Translating Discoveries from the Bench to the Bedside – bridging the critical gap between laboratory breakthroughs and clinical applications that impact patient lives.
Michael will be speaking on one of his favorite topics: Translating Discoveries from the Bench to the Bedside – bridging the critical gap between laboratory breakthroughs and clinical applications that impact patient lives.
This presentation offers valuable insights for researchers, clinicians, and industry professionals looking to navigate the complex journey of bringing innovations to market.
Interested in learning more about Michael’s work or CatalystBio’s approach to accelerating biomedical innovation? Connect with us at info@catalystbio.co
